Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aradigm Corp
(NQ:
ARDM
)
0.3833
USD
UNCHANGED
Last Price
Updated: 5:15 PM EST, Jan 14, 2019
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.3833
Bid (Size)
0.3000 (10)
Ask (Size)
0.4300 (30)
Prev. Close
0.3833
Today's Range
0.3833 - 0.3833
52wk Range
N/A - N/A
Shares Outstanding
15,211,472
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Aradigm Announces Effective Date of Modified Combined Chapter 11 Plan and Disclosure Statement
June 15, 2020
Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) announced on June 12, 2020, the Bankruptcy Court entered an order confirming the Debtor's Modified Combined Chapter 11 Plan and...
From
Business Wire News Releases
Aradigm Announces Conditional Approval for the Combined Chapter 11 Plan and Disclosure Statement
April 30, 2020
Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) announced on April 27, 2020, the Bankruptcy Court entered an order (i) conditionally approving the disclosure statement for the...
From
Business Wire News Releases
Performance
More News
Read More
Aradigm Announces Sale of Assets to Grifols, S.A.
April 03, 2020
From
Business Wire News Releases
Aradigm Announces Entering into an Asset Purchase Agreement with Grifols, S.A.
February 21, 2020
From
Business Wire News Releases
Aradigm Announces Withdrawal of European Marketing Authorization Application (MAA) for Linhaliq
October 30, 2019
From
Business Wire News Releases
Aradigm Receives Feedback Following an Oral Explanation With the European Medicines Agency
October 21, 2019
From
Business Wire News Releases
Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019
February 21, 2019
From
Business Wire News Releases
Aradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Code
February 15, 2019
From
Business Wire News Releases
Matinas BioPharma Appoints Global Pharmaceutical Drug Development Industry Leader Theresa Matkovits, Ph.D., Chief Development Officer; Further Expands Manufacturing and Clinical Development Team
October 15, 2018
From
GlobeNewswire News Releases
Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA
January 30, 2019
From
Business Wire News Releases
Consolidated Research: 2018 Summary Expectations for Community Health, Aradigm, Avnet, Sanchez Energy, Black Stone Minerals, and Navient — Fundamental Analysis, Key Performance Indications
September 25, 2018
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.